EBITDA: Income before interest, taxes, depreciation and amortization.
FibroBiologics Inc. (FBLG) had EBITDA of $-4.83M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.00M |
|
-- |
|
-- |
|
$5.07M |
|
$-5.07M |
|
$0.07M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.00M |
|
$-5.07M |
|
|
EBITDA |
$-4.83M |
3.77M |
|
3.77M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$2.90M |
|
$0.78M |
|
$3.03M |
|
$5.94M |
|
$1.83M |
|
-- |
|
$1.51M |
|
$3.34M |
|
$2.60M |
|
$2.60M |
|
$2.60M |
|
3.51M |
|
| Cash Flow Statement Financials | |
$-4.36M |
|
-- |
|
$0.95M |
|
$4.89M |
|
$1.48M |
|
$-3.41M |
|
$0.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.59 |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-192.31% |
|
-192.31% |
|
-84.20% |
|
-192.31% |
|
$0.74 |
|
$-1.16 |
|
$-1.16 |
|